[WS(P)03] In vivo model and new cancer immunotherapy

[WS03-06-O/P] PQDN improves CD8⁺ T cell metabolism by mitochondrial tuning resulting in improved cancer immunotherapy

^○Huimin Sun¹, Yosuke Dotsu¹, Daisuke Muraoka^1,2, Daisuke Kato⁴, Naohisa Ogo³, Yudai Sonoda³, Situo Deng¹, Kiyoshi Yasui¹, Mitsuhiro Yoneda¹, Hiromu Kondo⁴, Akira Asai³, Hiroaki Ikeda¹ (1.Department of Oncology, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki, Japan, 2.Division of Translational Oncoimmunology, Aichi Cancer Research Institute, Nagoya, Japan, 3.Center for Drug Discovery, Graduate School of Pharmaceutical Sciences, University of Shizuoka, Shizuoka, Japan, 4.Department of Pharmaceutical Engineering and Drug Delivery Science, School of Pharmaceutical Sciences, University of Shizuoka, Shizuoka, Japan)

キーワード：

T cells、MHC、T cell receptor (TCR)、T cell activation、Tumor heterogeneity

閲覧にはパスワードが必要です

ログイン

または